Toll‐like receptors: general molecular and structural biology

P Behzadi, HA García-Perdomo… - Journal of Immunology …, 2021 - Wiley Online Library
Background/Aim. Toll‐like receptors (TLRs) are pivotal biomolecules in the immune system.
Today, we are all aware of the importance of TLRs in bridging innate and adaptive immune …

Toll-like receptors as a therapeutic target in the era of immunotherapies

M Farooq, M Batool, MS Kim, S Choi - Frontiers in Cell and …, 2021 - frontiersin.org
Toll-like receptors (TLRs) are the pattern recognition receptors, which are activated by
foreign and host molecules in order to initiate the immune response. They play a crucial role …

Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma

Y Xun, H Yang, B Kaminska, H You - Journal of hematology & oncology, 2021 - Springer
Glioma represents a fast proliferating and highly invasive brain tumor which is resistant to
current therapies and invariably recurs. Despite some advancements in anti-glioma …

[HTML][HTML] The critical role of Toll-like receptor-mediated signaling in cancer immunotherapy

X Chen, Y Zhang, Y Fu - Medicine in Drug Discovery, 2022 - Elsevier
Toll-like receptors (TLR) play a dual regulatory role in the tumor microenvironment (TME).
TLR agonists (TLRa) elicit both innate and adaptive immune responses to achieve anti …

The role of toll-like receptor agonists and their nanomedicines for tumor immunotherapy

L Huang, X Ge, Y Liu, H Li, Z Zhang - Pharmaceutics, 2022 - mdpi.com
Toll-like receptors (TLRs) are a class of pattern recognition receptors that play a critical role
in innate and adaptive immunity. Toll-like receptor agonists (TLRa) as vaccine adjuvant …

Sepsis and cancer: an interplay of friends and foes

A Mirouse, C Vigneron, JF Llitjos… - American journal of …, 2020 - atsjournals.org
Sepsis and cancer share a number of pathophysiological features, and both result from the
inability of the host's immune system to cope with the initial insult (tissue invasion by …

MyD88-dependent BCG immunotherapy reduces tumor and regulates tumor microenvironment in bladder cancer murine model

NMGP de Queiroz, FV Marinho, ACVSC de Araujo… - Scientific reports, 2021 - nature.com
Abstract Bacillus Calmette-Guerin (BCG) is the only FDA approved first line therapy for
patients with nonmuscle invasive bladder cancer. The purpose of this study is to better …

Implications of Toll-like receptors (TLRs) and their signaling mechanisms in human cancers

SA Chandrasekar, T Palaniyandi… - … -Research and Practice, 2023 - Elsevier
Most essential pattern-recognition receptors regulating innate immune functions are toll-like
receptors (TLRs). TLRs are characterized by lack of concurrent epithelial markers and are …

[HTML][HTML] Pre-clinical investigation of STAT3 pathway in bladder cancer: paving the way for clinical translation

S Mirzaei, MH Gholami, MK Mahabady… - Biomedicine & …, 2021 - Elsevier
Effective cancer therapy requires identification of signaling networks and investigating their
potential role in proliferation and invasion of cancer cells. Among molecular pathways …

New perspectives in the medical treatment of non-muscle-invasive bladder cancer: immune checkpoint inhibitors and beyond

A Audisio, C Buttigliero, MD Delcuratolo, E Parlagreco… - Cells, 2022 - mdpi.com
Non-muscle-invasive bladder cancer (NMIBC) is characterized by a high rate of cure, but
also by a non-negligible probability of recurrence and risk progression to muscle-invasive …